Skip to content

Effects of dietary fiber-added diets on protein-binding toxoids and microinflammatory states in patients with chronic kidney disease

Effects of dietary fiber-added diets on protein-binding toxoids and microinflammatory states in patients with chronic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070381
Enrollment
Unknown
Registered
2023-04-11
Start date
2018-11-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Control group:Conventional low-salt, high-quality, low-protein diet (0.6-0.8 g/kg/d, 30-35 kcal/kg/d). After enrollment, all patients were fed a low-protein cake weighing 40-50 grams per day, with 10
Intervention group:Conventional low-salt, high-quality, low-protein diet (0.6-0.8 g/kg/d, 30-35 kcal/kg/d). After enrollment, all patients were enrolled in one low-protein cake with a raw weight of 40

Sponsors

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ? ages >18 years; ? estimated glomerular filtration rate (eGFR) of =44 mL/min/1.73 m2; ? accepting of dietary nutrition therapy; ? no cognitive and mental abnormalities, able to cooperate; ? volunteer to participate in this research and sign an informed consent form.

Exclusion criteria

Exclusion criteria: ? diagnosis with acute renal insufficiency; ? after active gastrointestinal disease or gastrointestinal surgery; ? patients with serious primary diseases such as heart, brain, lung, liver, hematopoietic system, etc; ? patients with malignant tumors, tuberculosis and other acute infectious diseases; ? patients who are using or have received corticosteroids or immunosuppressive drugs and nonsteroidal anti-inflammatory drugs in the past 3 months, and the course of treatment is more than one week; ? those who are participating in other drug-based clinical trials.

Design outcomes

Primary

MeasureTime frame
Serum p-cresol sulfate;Assessment of inflammatory states: IL-6 and hypersensitivity C-reactive protein;

Secondary

MeasureTime frame
Evaluation of gastrointestinal symptoms;Laboratory indicators: routine indicators include blood creatinine, blood urea nitrogen, albumin, prealbumin, transferrin, blood lipids, blood electrolytes, and hemoglobin.;Adherence assessment: package recycling and three-day dietary records.;Anthropometric measurements: height, weekly weight, upper arm muscle circumference, triceps skin fold thickness, waist circumference.;Quality of life level;

Countries

China

Contacts

Public ContactLiyang Chang

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University

changliyang@163.com15968868601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026